Growth hormone and aging: A challenging controversy

Clinical Interventions in Aging

Volumn 3, Issue 4, 2008, Pages 659-665

  Bartke, Andrzej ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti aging therapies; Cancer; Growth hormone; Longevity; Mutant mice

Indexed keywords

GROWTH HORMONE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADULTHOOD; AGING; ARTHRALGIA; BODY COMPOSITION; BODY GROWTH; BRAIN FUNCTION; CARPAL TUNNEL SYNDROME; DIABETES MELLITUS; EDEMA; FERTILITY; GENE FUNCTION; GENE MUTATION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; LIFE EXPECTANCY; LONGEVITY; NONHUMAN; PHENOTYPE; REVIEW; SEXUAL MATURATION; SIGNAL TRANSDUCTION; SOMATOPAUSE;

AGE FACTORS; AGING; ANIMALS; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS;

EID: 60749130050     PISSN: 11769092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. [A4M] American Academy of Anti-Aging Medicine. 2007. Analysis of faulty data yields inaccurate results: Thousands benefit from growth hormone replacement therapy for aging-related disorders - proven, real-world track record of benefits of adult growth hormone deficiency therapy disputes publication. A4M Official Response Statement [online]. Accessed on Oct 17, 2008. URL: http://www.worldhealth.net/news/ analysis_of_faulty_data_yields_inaccurat.
2. Arwert LI, Veltman DJ, Deijen B, et al. 2006. Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: A functional MRI study. Neuroendocrinology, 83:12-9.
3. Bartke A. 2003. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology, 78:210-6.
4. Bartke A, Brown-Borg PS. 2004a. Life extension in the dwarf mouse. In: Current Topics in Developmental Biology. San Diego: Academic Press, pp. 189-225.
5. Bartke A, Peluso MR, Moretz N, et al. 2004b. Effects of soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice. Horm Metab Res, 36:550-8.
6. Bartke A. 2006. Life extension in the dwarf mouse. In: Coon PM (ed). Handbook of models for the study of human aging. San Diego: Elsevier Academic Press, pp. 403-14.
7. Bartke A. 2007. Aging: All in the head? Cell Metabol, 6:153-4.
8. Bartke A. 2008. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings. Aging Cell, 7:285-90.
9. Baum HB, Katznelson L, Sherman JC, et al. 1998. Effects of a physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab, 83:3184-9.
10. Berryman DE, List EO, Coschigano KT, et al. 2004. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res, 14:309-18.
11. Besson A, Salemi S, Gallati S, et al. 2003. Reduced longevity in untreated patients with isolated growth hormone deficiency. J Clin Endocrinol Metab, 88:3664-7.
12. Blackman MR, Sorkin JD, Munzer T, et al. 2002. Growth hormone and sex steroid administration in healthy aged women and men: A randomized controlled trial. JAMA, 288:2282-92.
13. Bonkowski MS, Pamenter RW, Rocha JS, et al. 2006a. Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. J Gerontol A Biol Sci Med Sci, 61:562-7.
14. Bonkowski MS, Rocha JS, Masternak MM, et al. 2006b. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc Natl Acad Sci U S A, 103:7901-05.
15. Borg KE, Brown-Borg HM, Bartke A. 1995. Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse. Proc Soc for Exp Bio Med, 210:126-33.
16. Brosnahan MM, Paradis MR. 2003. Demographic and clinical characteristics of geriatric horses: 467 cases (1989-1999). J Am Vet Med Assoc, 223:93-8.
17. Brown-Borg HM, Borg KE, Meliska CJ, et al. 1996. Dwarf mice and the ageing process. Nature, 384:33.
18. Chandrashekar V, Bartke A, Coschigano KT, et al. 1999. Pituitary and testicular function in growth hormone receptor gene knockout mice. Endocrinology, 140:1082-8.
19. Conover CA, Bale LK. 2007. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell, 6:727-9.
20. Coschigano KT, Holland AN, Riders ME, et al. 2003. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology, 144:3799-810.
21. Dominici FP, Hauck S, Argentino DP, et al. 2002. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-I and IRS-2 in liver of Ames dwarf mice. J Endocrinol, 173:81-94.
22. Flurkey K, Papaconstantinou J, Miller RA, et al. 2001. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A, 98:6736-41.
23. Forsen T, Eriksson J, Qiao Q, et al. 2000. Short stature and coronary heart disease: a 35-year follow-up of the Finnish cohorts of The Seven Countries Study. J Int Med, 248:326-32.
24. Frutos MGS, Cacicedo L, Mendez CF, et al. 2007. Pituitary alterations involved in the decline of growth hormone gene expression in the pituitary of aging rats. J Gerontol A Biol Sci Med Sci, 62:585-97.
25. Giustina A, Veldhuis JD. 1998. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endo Rev, 19:717-97.
26. Goodman-Gruen D, Barrett-Connor E. 1997. Epidemiology of insulin-like growth factor-I in elderly men and women: The Rancho Bernardo Study. Am J Epidemiol, 145:970-6.
27. Greer K.A, Canterberry SC, Murphy KE. 2007. Statistical analysis regarding the effects of height and weight on life span of the domestic dog. Res Vet Sci, 82:208-14.
28. Groban L, Pailes NA, Bennett CDL, et al. 2006. Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats. J Gerontol A Biol Sci Med Sci, 61:28-35.
29. Gunnell D, Okasha M, Davey Smith G, et al. 2001. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev, 23:313-42.
30. Harper JM, Durkee SJ, Dysko RC, et al. 2006. Genetic modulation of hormone levels and life span in hybrids between laboratory and wild-derived mice. J Gerontol A Biol Sci Med Sci, 61:1019-29.
31. Heilbronn LK, de Jonge L, Frisard MI, et al. 2006. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: A randomized controlled trial. JAMA, 295:1539-48.
32. Holloszy JO, Fontana L. 2007. Caloric restriction in humans. Exp Gerontol, 42:709-12.
33. Holzenberger M, Dupont J, Ducos B, et al. 2003. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature, 421:182-7.
34. Ikeno Y, Bronson RT, Hubbard GB, et al. 2003. Delayed occurrence of fatal neoplastic diseases in Ames dwarf mice: correlation to extended longevity. J Gerontol A. Biol Sci Med Sci, 58A:291-6.
35. Jadresic A, Banks LM, Child DF, et al. 1982. The acromegaly syndrome. Quart J Med, 202:189-204.
36. Keene DF, Suescun MO, Bostwick MG, et al. 2002. Puberty in male growth hormone receptor gene disrupted mice. J Androl, 23:661-8.
37. Kinney BA, Coschigano KT, Kopchick JJ, et al. 2001a. Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice. Physiol Behav, 72:653-60.
38. Kinney BA, Meliska CJ, Steger RW, et al. 2001b. Evidence that Ames dwarf mice age differently from their normal siblings in behavioral and learning and memory parameters. Horm Behav, 39:277-84.
39. Krzisnik C, Kolacio Z, Battelino T, et al. 1999. The "Little People" of the island of Krk - revisited. Etiology of hypopituitarism revealed. J Endo Gene, 1:9-19.
40. Kuwahara S, Kesuma Sari D, Tsukamoto Y, et al. 2004. Age-related changes in growth hormone (GH)-releasing hormone and somatostatin neurons in the hypothalamus and in GH cells in the anterior pituitary of female mice. Brain Res, 1025:113-22.
41. Lamberts SWJ, van den Beld AW, van der Lel A-J. 1997. The endocrinology of aging. Science, 278:419-24.
42. Laron Z. 2005. Do deficiencies in growth hormone and insulin-like growth factor-I (IGF-1) shorten or prolong longevity? Mech Ageing Dev, 126:305-7.
43. Littman AJ, White E, Kristal AR. 2007. Anthropometrics and prostate cancer risk. Am J Epidemiol, 165:1271-9.
44. Liu H, Bravata DM, Olkin I, et al. 2007. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med, 146:104-15.
45. Liu J-L, Coschigano KT, Robertson K, et al. 2004. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab, 287:E405-13.
46. Maggio M, Ble A, Ceda GP, et al. 2006. Decline in insulin-like growth factor-1 levels across adult life span in two large population studies. J Gerontol A Biol Sci Med Sci, 61:182-3.
47. Masoro EJ. 2001. Dietary restriction: An experimental approach to the study ofthe biology of aging. In: Masoro EJ, Austad SN (editors). Handbook of The Biology of Aging. Fifth Edition. San Diego: Academic Press, pp. 396-420.
48. Menezes Oliveira JL, Marques-Santos C, Barreto-Filho JA, et al. 2006. Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation. J Clin Endocrinol Metab, 91:2093-9.
49. Miller RA, Harper JM, Galecki A, et al. 2002. Big mice die young: early life body weight predicts longevity in genetically heterogeneous mice. Aging Cell, 1:22-9.
50. Orme SM, McNally RJQ, Cartwright RA, et al. 1998. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab, 83:2730-4.
51. Papadakis MA, Grady D, Black D, et al. 1996. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med, 124:708-16.
52. Parsons JA, Bartke A, Sorenson RL. 1995. Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: Effect of lactogenic hormones. Endocrinology, 136:2013-21.
53. Partridge L, Gems D, Withers, DJ. 2005. Sex and death: What is the connection? Cell, 120:461-72.
54. Patronek GJ, Waters DJ, Glickman LT. 1997. Comparative longevity of pet dogs and humans: implications for gerontology research. J Gerontol A Biol Sci Med Sci, 52A:B171-8.
55. Ramsey MM, Weiner JL, Moore TP, et al. 2004. Growth hormone treatment attenuates age-related changes in hippocampal short-term plasticity and spatial learning. Neuroscience, 129:119-27.
56. Roberts RC. 1961. The lifetime growth and reproduction of selected strains of mice. Heredity, 16:369-81.
57. Rollo CD. 2002. Growth negatively impacts the life span of mammals. Evol Dev, 4:55-61.
58. Rudman D, Feller AG, Nagraj HS, et al. 1990. Effects of human growth hormone in men over 60 years old. N Engl J Med, 323:1-6.
59. Sacca L, Cittadini A, Fazio S. 1994. Growth hormone and the heart. Endocr Rev, 15:555-73.
60. Sacca L, Napoli R, Cittadini A. 2003. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Clin Endocrinol, 59:660-71.
61. Samaras TT, Storms LH. 2002. Secular growth and its harmful ramifications. Med Hypotheses, 58:93-112.
62. Samaras T. 2007. Human body size and the laws of scaling: Physiological, performance, growth, longevity and ecological ramifications. New York: Nova Science Publishers, Inc.
63. Schnaider Beeri M, Davidson M, Silverman JM, et al. 2005. Relationship between body height and dementia. Am J Geriatr Psychiatry, 13:116-23.
64. Sell C, Lorenzini S. 2007. Aging in IGF-1 hypomorphic mice, The American Aging Association 36th Annual Meeting. American Aging Association, San Antonio, TX.
65. Selman C, Lingard S, Choudhury AI, et al. 2008. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB, 22:807-18.
66. Shalet SM, Toogood A, Rahim A, et al. 1998. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev, 19:203-23.
67. Shechter M, Ginsberg S, Scheinowitz M, et al. 2007. Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function. Growth Horm IGF Res, 17:165-70.
68. Shevah O, Laron Z. 2007. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm ICF Res, 17:54-7.
69. Shimokawa I, Higami Y, Utsuyama M, et al. 2002. Lifespan extension by reduction of the growth hormone-insulin-like growth factor-I axis: relation to caloric restriction. Am J Pathol, 160:2259-65.
70. Silberberg R. 1972. Articular aging and osteoarthrosis in dwarf mice. Pathol Microbiol (Basel), 38:417-30.
71. Sonntag EW, Steger RW, Forman JL, et al. 1980. Decreased pulsatile release of growth hormone in old male rats. Endocrinology, 107:1875-9.
72. Sonntag WE, Carter CS, Ikeno Y, et al. 2005a. Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology, 146:2920-32.
73. Sonntag WE, Ramsey M, Carter CS. 2005b. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev, 4:195-212.
74. Sub Y, Atzmon G, Cho M-O, et al. 2008. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A, 105:3438-42.
75. Taguchi A, Wartschow LM, White MF. 2007. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science, 317:369-72.
76. Tretli S. 1989. Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer, 44:23-30.
77. von Werder K. 1999. The somatopause is no indication for growth hormone therapy. J Endocrinol Invest, 22:137-41.
78. Zaczek DJ, Hammond JM, Suen L, et al. 2002. Impact of growth hormone resistance on female reproductive function: New insight from growth hormone receptor knockout mice. Biol Reprod, 67:1115-24.
79. Zhou Y, Xu BC, Maheshwari HG, et al. 1997. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Nat Acad Sci U S A, 94:13215-20.